课题基金 / 基金详情

Resilient and Low-Footprint Electric Vehicle Charging Infrastructure

Resilient and Low-Footprint Electric Vehicle Charging Infrastructure
弹性且占地面积小的电动汽车充电基础设施
批准号:
577176-2022
负责人:
BadrkhaniAjaei, FirouzF
金额:
$18.37万
依托单位国家:
加拿大
项目类别:
Alliance Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Canada's plans for recovery from the pandemic must include strong action to tackle climate change, according to Prime Minister Trudeau. However, Canada's climate policies and actions have been rated as "Highly Insufficient". Only 5% of the passenger vehicles registered in 2021 in Canada were Electric Vehicles (EVs). One of the major reasons for this relatively low EV adoption rate is the shortage of publicly available charging infrastructures. Comparing the EV market share and public fast charger availability in some of the world-leading countries/states and Canada indicates that full transition to zero-emission vehicles in Canada requires nationwide deployment of EV chargers. Developing the urgently needed EV charging stations in different regions of Canada requires addressing multiple technical and economic challenges. These include (i) need for additional power generation, transmission, and distribution capacities to meet the extra charging power demand especially in densely populated urban areas, (ii) risk of electric transportation disruption due to utility grid outages, especially during natural disasters, and (iv) cybersecurity concerns. The proposed research program aims to address these challenges by developing an innovative EV charging solution that is based on a low-footprint rotary parking tower structure and a microgrid framework that leads to resilience against natural disasters, blackouts, and faults.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
骨髓微环境中正常造血干/祖细胞新亚群IL7Rα(-)LSK(low)细胞延缓急性髓系白血病进程的作用及机制研究
MSCEN聚集体抑制CD127low单核细胞铜死亡治疗SLE 的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    耿林玉
  • 依托单位:
新型PDL1+CXCR2low中性粒细胞在脉络膜新生血管中的作用及机制研究
  • 批准号:
    82271095
  • 项目类别:
    面上项目
  • 资助金额:
    56万元
  • 批准年份:
    2022
  • 负责人:
    柳夏林
  • 依托单位:
CD9+CD55low脂肪前体细胞介导高脂诱导脂肪组织炎症和2型糖尿病的作用和机制研究
  • 批准号:
    82270883
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    毕艳
  • 依托单位: